Stock Events

Stock Events

Amyris 

$0
161
+$0+0% Tuesday 16:59

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-195.86%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
269.85MRevenue
-528.51MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMRSQ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evogene
EVGN
Mkt Cap9.54M
Evogene operates in the biotechnology sector focusing on the development of products for various industries including chemicals and agriculture, overlapping with Amyris' market.
Codexis
CDXS
Mkt Cap240.8M
Codexis specializes in protein engineering and enzyme innovation, competing with Amyris in the market for sustainable chemical processes.
Gevo
GEVO
Mkt Cap437.19M
Gevo is involved in the renewable chemicals and advanced biofuels market, making it a competitor in Amyris' renewable product space.
Gracell Biotechnologies
GRCL
Mkt Cap989.87M
Grisel Industries competes in the biotech space, focusing on sustainable and environmentally friendly products, similar to Amyris' goals.
Synlogic
SYBX
Mkt Cap7.39M
Synlogic operates in the synthetic biology field, developing therapeutic drugs and competing with Amyris in the biotech innovation space.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap0
DSM is a global science-based company active in health, nutrition, and materials, competing with Amyris in the production of sustainable and bio-based products.
Archer Daniels Midland
ADM
Mkt Cap33.36B
Archer Daniels Midland Company is a global leader in bioenergy and naturally derived products, competing with Amyris in the broader market for sustainable biochemicals and biofuels.

About

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. John G. Melo
Employees
980
Country
United States
ISIN
US03236M2008
WKN
000A2DS41

Listings

0 Comments

Share your thoughts

FAQ

What is Amyris stock price today?▼
The current price of AMRSQ is $0 USD — it has increased by +0% in the past 24 hours. Watch Amyris stock price performance more closely on the chart.
What is Amyris stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Amyris stocks are traded under the ticker AMRSQ.
What is Amyris revenue for the last year?▼
Amyris revenue for the last year amounts to 269.85M USD.
What is Amyris net income for the last year?▼
AMRSQ net income for the last year is -528.51M USD.
How many employees does Amyris have?▼
As of April 29, 2026, the company has 980 employees.
In which sector is Amyris located?▼
Amyris operates in the Other sector.
When did Amyris complete a stock split?▼
Amyris has not had any recent stock splits.
Where is Amyris headquartered?▼
Amyris is headquartered in EmeryVille, United States.